Back To Search Instructions
11 protocols meet the specified criteria
Disease Site: Brain and Nervous System
Protocol No.TitleStatus
0600000199Phase III Randomized Study of Chimeric Antibody 14.18 (CH14.18) in High Risk Neuroblastoma Following Myeloablative Therapy and Autologous Stem Cell RescueOpen
0600000250A Study Evaluating Limited Target Volume Boost Irradiation and Reduced Dose Craniospinal Radiotherapy 18.00 Gy and Chemotherapy in Children with Newly Diagnosed Standard Risk MedulloblastomaOpen
0600000406A Phase III Randomized Trial of Intravenous Gammaglobulin Therapy for Patients with Neuroblastoma-Associated Opsoclonus-Myoclonus-Ataxia Syndrome Treated with Chemotherapy and PrednisoneOpen
0800000071COG ANBL0531: Response and Biology-Based Therapy for Intermediate-Risk NeuroblastomaOpen
0800000327COG ANBL0532 Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk NeuroblastomaOpen
1000000222Phase II/III Study of Image-Guided Radiosurgery/SBRT for Localized Spine Metastasis (RTOG 0631)Open
1000000393Treatment of Recurrent or Resistant Pediatric Malignant Germ Cell Tumors with Paclitaxel, Ifosfamide and Carboplatin (COG AGCT0521)Open
1200000557A Randomized, Double-Blind, Phase 2, Dose-Ranging Study to Evaluate the Safety and Efficacy of Veliparib and Whole Brain Radiation Therapy Versus Placebo and Whole Brain Radiation Therapy in Subjects with Brain Metastases from Non-Small Cell Lung Cancer (M10-897)Open
1200000750An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF with Adjuvant Temozolomide in Patients with Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma CDX110-04 (ACT IV)Open
1300000005RTOG 1205 Randomized Phase II Trial of Concurrent Bevacizumab and Re-Irradiation versus Bevacizumab Alone as Treatment for Recurrent GlioblastomaOpen
1312169092A Pilot Study of the Combination of Nab-paclitaxel, Temozolomide and Bevacizumab in Patients with Metastatic Melanoma with Brain MetastasesOpen